Literature DB >> 15718504

Mixed messages: transcription patterns in failing and recovering human myocardium.

Kenneth B Margulies1, Sunil Matiwala, Carla Cornejo, Henrik Olsen, William A Craven, Daniel Bednarik.   

Abstract

In previous studies, mechanical support of medically refractory hearts with a left ventricular assist device (LVAD) has induced regression of many morphological and functional abnormalities characteristic of failing human hearts. To identify transcriptional adaptations in failing and LVAD-supported hearts, we performed a comprehensive transcription analysis using the Affymetrix microarray platform and 199 human myocardial samples from nonfailing, failing, and LVAD-supported human hearts. We also used a novel analytical strategy that defines patterns of interest based on multiple intergroup comparisons. Although over 3088 transcripts exhibited significantly altered abundance in heart failure, most of these did not exhibit a consistent response to LVAD support based on our analysis. Of those 238 with a consistent response to LVAD support, more than 75% exhibited persistence or exacerbation of HF-associated transcriptional abnormalities whereas only 11%, 5%, and 2% exhibited partial recovery, normalization, and overcorrection responses, respectively. Even among genes implicated by previous reports of LVAD-associated myocardial improvements, partial or complete normalization of transcription did not predominate. The magnitude of differences in transcript abundance between nonfailing and failing hearts, and between failing an LVAD-supported hearts, tended to be low with changes greater than or equal to 2-fold infrequently observed. Our results indicate that morphological or functional myocardial improvements may occur without widespread normalization of pathological transcriptional patterns. These observations also suggest that many failure-associated transcriptional changes have only a limited role in regulating cardiac structure and function and may represent epiphenomena and/or nonspecific myocardial plasticity responses. Differences in mRNA localization, translation efficiency, and posttranslational protein modifications or interactions may be more pivotal in regulating myocardial structure and function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15718504     DOI: 10.1161/01.RES.0000159390.03503.c3

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  69 in total

Review 1.  Transcriptome, proteome, and metabolome in dyssynchronous heart failure and CRT.

Authors:  Andreas S Barth; Khalid Chakir; David A Kass; Gordon F Tomaselli
Journal:  J Cardiovasc Transl Res       Date:  2012-02-07       Impact factor: 4.132

Review 2.  Is myocardial recovery possible and how do you measure it?

Authors:  Douglas L Mann; Daniel Burkhoff
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

Review 3.  Therapeutic potential of microRNAs in heart failure.

Authors:  Gerald W Dorn
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

4.  Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation.

Authors:  Saptarsi M Haldar; Yuan Lu; Darwin Jeyaraj; Daiji Kawanami; Yingjie Cui; Sam J Eapen; Caili Hao; Yan Li; Yong-Qiu Doughman; Michiko Watanabe; Koichi Shimizu; Helena Kuivaniemi; Junichi Sadoshima; Kenneth B Margulies; Thomas P Cappola; Mukesh K Jain
Journal:  Sci Transl Med       Date:  2010-04-07       Impact factor: 17.956

5.  Bridge to recovery: understanding the disconnect between clinical and biological outcomes.

Authors:  Stavros G Drakos; Abdallah G Kfoury; Josef Stehlik; Craig H Selzman; Bruce B Reid; John V Terrovitis; John N Nanas; Dean Y Li
Journal:  Circulation       Date:  2012-07-10       Impact factor: 29.690

6.  Deep sequencing of cardiac microRNA-mRNA interactomes in clinical and experimental cardiomyopathy.

Authors:  Scot J Matkovich; Gerald W Dorn
Journal:  Methods Mol Biol       Date:  2015

7.  Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support.

Authors:  Scot J Matkovich; Derek J Van Booven; Keith A Youker; Guillermo Torre-Amione; Abhinav Diwan; William H Eschenbacher; Lisa E Dorn; Mark A Watson; Kenneth B Margulies; Gerald W Dorn
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

Review 8.  MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Authors:  V Sala; S Bergerone; S Gatti; S Gallo; A Ponzetto; C Ponzetto; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

9.  The chromatin-binding protein Smyd1 restricts adult mammalian heart growth.

Authors:  Sarah Franklin; Todd Kimball; Tara L Rasmussen; Manuel Rosa-Garrido; Haodong Chen; Tam Tran; Mickey R Miller; Ricardo Gray; Shanxi Jiang; Shuxun Ren; Yibin Wang; Haley O Tucker; Thomas M Vondriska
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-23       Impact factor: 4.733

10.  Ventricular arrhythmias after left ventricular assist device implantation.

Authors:  Marwan Refaat; Elie Chemaly; Djamel Lebeche; Judith K Gwathmey; Roger J Hajjar
Journal:  Pacing Clin Electrophysiol       Date:  2008-10       Impact factor: 1.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.